Palatin Technologies Inc - Major Products and Services
Palatin Technologies Inc - History
Palatin Technologies Inc - Company Statement
Palatin Technologies Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Palatin Technologies Inc - Business Description
Palatin Technologies Inc - Corporate Strategy
Palatin Technologies Inc - SWOT Analysis
SWOT Analysis - Overview
Palatin Technologies Inc - Strengths
Palatin Technologies Inc - Weaknesses
Palatin Technologies Inc - Opportunities
Palatin Technologies Inc - Threats
Palatin Technologies Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Palatin Technologies Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Oct 23, 2024: Palatin Presents Foundational Data on Novel and Highly Selective Melanocortin 4 Receptor Agonists at the 19th Annual Peptide Therapeutics Symposium
Sep 09, 2024: Palatin Provides Update on Clinical Programs, Strategic Priorities, and Anticipated Milestones
May 16, 2024: Palatin Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
Jan 08, 2024: Palatin Provides Corporate Update and Highlights Strategic Priorities for Calendar Year 2024
Oct 19, 2023: Palatin Announces Preliminary Quarter Ended September 30, 2023 Vyleesi Product Revenue Results
May 16, 2023: Palatin reports third quarter fiscal year 2023 financial results and provides corporate update
May 11, 2023: Palatin to report Q3 fiscal year 2023 results; teleconference and webcast to be held on May 16, 2023